Florida Senate - 2019 COMMITTEE AMENDMENT
Bill No. CS for SB 182
Senate . House
Comm: RCS .
The Committee on Innovation, Industry, and Technology (Brandes)
recommended the following:
1 Senate Amendment (with title amendment)
3 Delete everything after the enacting clause
4 and insert:
5 Section 1. Paragraphs (g) and (j) of subsection (1),
6 paragraph (a) of subsection (4), paragraph (e) of subsection
7 (8), subsection (14), and subsection (15) of section 381.986,
8 Florida Statutes, are amended to read:
9 381.986 Medical use of marijuana.—
10 (1) DEFINITIONS.—As used in this section, the term:
11 (g) “Marijuana delivery device” means an object used,
12 intended for use, or designed for use in preparing, storing,
13 ingesting, inhaling, or otherwise introducing marijuana into the
14 human body, and which is dispensed from a medical marijuana
15 treatment center for medical use by a qualified patient, except
16 that delivery devices intended for the medical use of marijuana
17 by smoking need not be dispensed from a medical marijuana
18 treatment center in order to qualify as marijuana delivery
20 (j) “Medical use” means the acquisition, possession, use,
21 delivery, transfer, or administration of marijuana authorized by
22 a physician certification. The term does not include:
23 1. Possession, use, or administration of marijuana that was
24 not purchased or acquired from a medical marijuana treatment
26 2. Possession, use, or administration of marijuana in
27 form for smoking, in the form of commercially produced food
28 items other than edibles , or of marijuana seeds or flower,
29 except for flower in a sealed, tamper-proof receptacle for
31 3. Use or administration of any form or amount of marijuana
32 in a manner that is inconsistent with the qualified physician’s
33 directions or physician certification.
34 4. Transfer of marijuana to a person other than the
35 qualified patient for whom it was authorized or the qualified
36 patient’s caregiver on behalf of the qualified patient.
37 5. The smoking of marijuana in an enclosed indoor workplace
38 as defined in s. 386.203(5).
39 6. 5. Use or administration of marijuana in the following
41 a. On any form of public transportation, except for low-THC
43 b. In any public place, except for low-THC cannabis.
44 c. In a qualified patient’s place of employment, except
45 when permitted by his or her employer.
46 d. In a state correctional institution, as defined in s.
47 944.02, or a correctional institution, as defined in s. 944.241.
48 e. On the grounds of a preschool, primary school, or
49 secondary school, except as provided in s. 1006.062.
50 f. In a school bus, a vehicle, an aircraft, or a motorboat,
51 except for low-THC cannabis.
53 For the purposes of this subparagraph, the exceptions for low
54 THC cannabis do not include the smoking of low-THC cannabis.
55 (4) PHYSICIAN CERTIFICATION.—
56 (a) A qualified physician may issue a physician
57 certification only if the qualified physician:
58 1. Conducted a physical examination while physically
59 present in the same room as the patient and a full assessment of
60 the medical history of the patient.
61 2. Diagnosed the patient with at least one qualifying
62 medical condition.
63 3. Determined that the medical use of marijuana would
64 likely outweigh the potential health risks for the patient, and
65 such determination must be documented in the patient’s medical
66 record. If a patient is younger than 18 years of age, a second
67 physician must concur with this determination, and such
68 concurrence must be documented in the patient’s medical record.
69 4. Determined whether the patient is pregnant and
70 documented such determination in the patient’s medical record. A
71 physician may not issue a physician certification, except for
72 low-THC cannabis, to a patient who is pregnant.
73 5. Reviewed the patient’s controlled drug prescription
74 history in the prescription drug monitoring program database
75 established pursuant to s. 893.055.
76 6. Reviews the medical marijuana use registry and confirmed
77 that the patient does not have an active physician certification
78 from another qualified physician.
79 7. Registers as the issuer of the physician certification
80 for the named qualified patient on the medical marijuana use
81 registry in an electronic manner determined by the department,
83 a. Enters into the registry the contents of the physician
84 certification, including the patient’s qualifying condition and
85 the dosage not to exceed the daily dose amount determined by the
86 department, the amount and forms of marijuana authorized for the
87 patient, and any types of marijuana delivery devices needed by
88 the patient for the medical use of marijuana.
89 b. Updates the registry within 7 days after any change is
90 made to the original physician certification to reflect such
92 c. Deactivates the registration of the qualified patient
93 and the patient’s caregiver when the physician no longer
94 recommends the medical use of marijuana for the patient.
95 8. Obtains the voluntary and informed written consent of
96 the patient for medical use of marijuana each time the qualified
97 physician issues a physician certification for the patient,
98 which shall be maintained in the patient’s medical record. The
99 patient, or the patient’s parent or legal guardian if the
100 patient is a minor, must sign the informed consent acknowledging
101 that the qualified physician has sufficiently explained its
102 content. The qualified physician must use a standardized
103 informed consent form adopted in rule by the Board of Medicine
104 and the Board of Osteopathic Medicine, which must include, at a
105 minimum, information related to:
106 a. The Federal Government’s classification of marijuana as
107 a Schedule I controlled substance.
108 b. The approval and oversight status of marijuana by the
109 Food and Drug Administration.
110 c. The current state of research on the efficacy of
111 marijuana to treat the qualifying conditions set forth in this
113 d. The potential for addiction.
114 e. The potential effect that marijuana may have on a
115 patient’s coordination, motor skills, and cognition, including a
116 warning against operating heavy machinery, operating a motor
117 vehicle, or engaging in activities that require a person to be
118 alert or respond quickly.
119 f. The potential side effects of marijuana use.
120 g. The risks, benefits, and drug interactions of marijuana.
121 h. The risks specifically associated with smoking
123 i. h. That the patient’s de-identified health information
124 contained in the physician certification and medical marijuana
125 use registry may be used for research purposes.
127 For a patient not diagnosed with a terminal condition, if the
128 patient is younger than 18 years of age and the certifying
129 physician intends to certify the patient’s medical use of
130 marijuana by way of smoking, the certifying physician must
131 determine that smoking is the most effective means of
132 administering medical marijuana for the patient and a second
133 physician must concur with that determination. The second
134 physician must be a pediatrician. Such determination and
135 concurrence must be documented in the patient’s medical record.
136 (8) MEDICAL MARIJUANA TREATMENT CENTERS.—
137 (e) A licensed medical marijuana treatment center shall
138 cultivate, process, transport, and dispense marijuana for
139 medical use. A licensed medical marijuana treatment center may
140 not contract for services directly related to the cultivation,
141 processing, and dispensing of marijuana or marijuana delivery
142 devices, except that a medical marijuana treatment center
143 licensed pursuant to subparagraph (a)1. may contract with a
144 single entity for the cultivation, processing, transporting, and
145 dispensing of marijuana and marijuana delivery devices. A
146 licensed medical marijuana treatment center must, at all times,
147 maintain compliance with the criteria demonstrated and
148 representations made in the initial application and the criteria
149 established in this subsection. Upon request, the department may
150 grant a medical marijuana treatment center a variance from the
151 representations made in the initial application. Consideration
152 of such a request shall be based upon the individual facts and
153 circumstances surrounding the request. A variance may not be
154 granted unless the requesting medical marijuana treatment center
155 can demonstrate to the department that it has a proposed
156 alternative to the specific representation made in its
157 application which fulfills the same or a similar purpose as the
158 specific representation in a way that the department can
159 reasonably determine will not be a lower standard than the
160 specific representation in the application. A variance may not
161 be granted from the requirements in subparagraph 2. and
162 subparagraphs (b)1. and 2.
163 1. A licensed medical marijuana treatment center may
164 transfer ownership to an individual or entity who meets the
165 requirements of this section. A publicly traded corporation or
166 publicly traded company that meets the requirements of this
167 section is not precluded from ownership of a medical marijuana
168 treatment center. To accommodate a change in ownership:
169 a. The licensed medical marijuana treatment center shall
170 notify the department in writing at least 60 days before the
171 anticipated date of the change of ownership.
172 b. The individual or entity applying for initial licensure
173 due to a change of ownership must submit an application that
174 must be received by the department at least 60 days before the
175 date of change of ownership.
176 c. Upon receipt of an application for a license, the
177 department shall examine the application and, within 30 days
178 after receipt, notify the applicant in writing of any apparent
179 errors or omissions and request any additional information
181 d. Requested information omitted from an application for
182 licensure must be filed with the department within 21 days after
183 the department’s request for omitted information or the
184 application shall be deemed incomplete and shall be withdrawn
185 from further consideration and the fees shall be forfeited.
187 Within 30 days after the receipt of a complete application, the
188 department shall approve or deny the application.
189 2. A medical marijuana treatment center, and any individual
190 or entity who directly or indirectly owns, controls, or holds
191 with power to vote 5 percent or more of the voting shares of a
192 medical marijuana treatment center, may not acquire direct or
193 indirect ownership or control of any voting shares or other form
194 of ownership of any other medical marijuana treatment center.
195 3. A medical marijuana treatment center may not enter into
196 any form of profit-sharing arrangement with the property owner
197 or lessor of any of its facilities where cultivation,
198 processing, storing, or dispensing of marijuana and marijuana
199 delivery devices occurs.
200 4. All employees of a medical marijuana treatment center
201 must be 21 years of age or older and have passed a background
202 screening pursuant to subsection (9).
203 5. Each medical marijuana treatment center must adopt and
204 enforce policies and procedures to ensure employees and
205 volunteers receive training on the legal requirements to
206 dispense marijuana to qualified patients.
207 6. When growing marijuana, a medical marijuana treatment
209 a. May use pesticides determined by the department, after
210 consultation with the Department of Agriculture and Consumer
211 Services, to be safely applied to plants intended for human
212 consumption, but may not use pesticides designated as
213 restricted-use pesticides pursuant to s. 487.042.
214 b. Must grow marijuana within an enclosed structure and in
215 a room separate from any other plant.
216 c. Must inspect seeds and growing plants for plant pests
217 that endanger or threaten the horticultural and agricultural
218 interests of the state in accordance with chapter 581 and any
219 rules adopted thereunder.
220 d. Must perform fumigation or treatment of plants, or
221 remove and destroy infested or infected plants, in accordance
222 with chapter 581 and any rules adopted thereunder.
223 7. Each medical marijuana treatment center must produce and
224 make available for purchase at least one low-THC cannabis
226 8. A medical marijuana treatment center that produces
227 edibles must hold a permit to operate as a food establishment
228 pursuant to chapter 500, the Florida Food Safety Act, and must
229 comply with all the requirements for food establishments
230 pursuant to chapter 500 and any rules adopted thereunder.
231 Edibles may not contain more than 200 milligrams of
232 tetrahydrocannabinol, and a single serving portion of an edible
233 may not exceed 10 milligrams of tetrahydrocannabinol. Edibles
234 may have a potency variance of no greater than 15 percent.
235 Edibles may not be attractive to children; be manufactured in
236 the shape of humans, cartoons, or animals; be manufactured in a
237 form that bears any reasonable resemblance to products available
238 for consumption as commercially available candy; or contain any
239 color additives. To discourage consumption of edibles by
240 children, the department shall determine by rule any shapes,
241 forms, and ingredients allowed and prohibited for edibles.
242 Medical marijuana treatment centers may not begin processing or
243 dispensing edibles until after the effective date of the rule.
244 The department shall also adopt sanitation rules providing the
245 standards and requirements for the storage, display, or
246 dispensing of edibles.
247 9. Within 12 months after licensure, a medical marijuana
248 treatment center must demonstrate to the department that all of
249 its processing facilities have passed a Food Safety Good
250 Manufacturing Practices, such as Global Food Safety Initiative
251 or equivalent, inspection by a nationally accredited certifying
252 body. A medical marijuana treatment center must immediately stop
253 processing at any facility which fails to pass this inspection
254 until it demonstrates to the department that such facility has
255 met this requirement.
256 10. When processing marijuana, a medical marijuana
257 treatment center must:
258 a. Process the marijuana within an enclosed structure and
259 in a room separate from other plants or products.
260 b. Comply with department rules when processing marijuana
261 with hydrocarbon solvents or other solvents or gases exhibiting
262 potential toxicity to humans. The department shall determine by
263 rule the requirements for medical marijuana treatment centers to
264 use such solvents or gases exhibiting potential toxicity to
266 c. Comply with federal and state laws and regulations and
267 department rules for solid and liquid wastes. The department
268 shall determine by rule procedures for the storage, handling,
269 transportation, management, and disposal of solid and liquid
270 waste generated during marijuana production and processing. The
271 Department of Environmental Protection shall assist the
272 department in developing such rules.
273 d. Test the processed marijuana using a medical marijuana
274 testing laboratory before it is dispensed. Results must be
275 verified and signed by two medical marijuana treatment center
276 employees. Before dispensing, the medical marijuana treatment
277 center must determine that the test results indicate that low
278 THC cannabis meets the definition of low-THC cannabis, the
279 concentration of tetrahydrocannabinol meets the potency
280 requirements of this section, the labeling of the concentration
281 of tetrahydrocannabinol and cannabidiol is accurate, and all
282 marijuana is safe for human consumption and free from
283 contaminants that are unsafe for human consumption. The
284 department shall determine by rule which contaminants must be
285 tested for and the maximum levels of each contaminant which are
286 safe for human consumption. The Department of Agriculture and
287 Consumer Services shall assist the department in developing the
288 testing requirements for contaminants that are unsafe for human
289 consumption in edibles. The department shall also determine by
290 rule the procedures for the treatment of marijuana that fails to
291 meet the testing requirements of this section, s. 381.988, or
292 department rule. The department may select a random sample from
293 edibles available for purchase in a dispensing facility which
294 shall be tested by the department to determine that the edible
295 meets the potency requirements of this section, is safe for
296 human consumption, and the labeling of the tetrahydrocannabinol
297 and cannabidiol concentration is accurate. A medical marijuana
298 treatment center may not require payment from the department for
299 the sample. A medical marijuana treatment center must recall
300 edibles, including all edibles made from the same batch of
301 marijuana, which fail to meet the potency requirements of this
302 section, which are unsafe for human consumption, or for which
303 the labeling of the tetrahydrocannabinol and cannabidiol
304 concentration is inaccurate. The medical marijuana treatment
305 center must retain records of all testing and samples of each
306 homogenous batch of marijuana for at least 9 months. The medical
307 marijuana treatment center must contract with a marijuana
308 testing laboratory to perform audits on the medical marijuana
309 treatment center’s standard operating procedures, testing
310 records, and samples and provide the results to the department
311 to confirm that the marijuana or low-THC cannabis meets the
312 requirements of this section and that the marijuana or low-THC
313 cannabis is safe for human consumption. A medical marijuana
314 treatment center shall reserve two processed samples from each
315 batch and retain such samples for at least 9 months for the
316 purpose of such audits. A medical marijuana treatment center may
317 use a laboratory that has not been certified by the department
318 under s. 381.988 until such time as at least one laboratory
319 holds the required certification, but in no event later than
320 July 1, 2018.
321 e. Package the marijuana in compliance with the United
322 States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss.
323 1471 et seq.
324 f. Package the marijuana in a receptacle that has a firmly
325 affixed and legible label stating the following information:
326 (I) The marijuana or low-THC cannabis meets the
327 requirements of sub-subparagraph d.
328 (II) The name of the medical marijuana treatment center
329 from which the marijuana originates.
330 (III) The batch number and harvest number from which the
331 marijuana originates and the date dispensed.
332 (IV) The name of the physician who issued the physician
334 (V) The name of the patient.
335 (VI) The product name, if applicable, and dosage form,
336 including concentration of tetrahydrocannabinol and cannabidiol.
337 The product name may not contain wording commonly associated
338 with products marketed by or to children.
339 (VII) The recommended dose.
340 (VIII) A warning that it is illegal to transfer medical
341 marijuana to another person.
342 (IX) A marijuana universal symbol developed by the
344 11. The medical marijuana treatment center shall include in
345 each package a patient package insert with information on the
346 specific product dispensed related to:
347 a. Clinical pharmacology.
348 b. Indications and use.
349 c. Dosage and administration.
350 d. Dosage forms and strengths.
351 e. Contraindications.
352 f. Warnings and precautions.
353 g. Adverse reactions.
354 12. In addition to the packaging and labeling requirements
355 in subparagraphs 10. and 11., marijuana in a form for smoking
356 must be packaged in a sealed receptacle with a legible and
357 prominent warning to keep away from children and a warning that
358 states marijuana smoke contains carcinogens and may negatively
359 affect health. Such receptacles for marijuana in a form for
360 smoking must be plain, opaque, and white without depictions of
361 the product or images other than the medical marijuana treatment
362 center’s department-approved logo and the marijuana universal
364 13. 12. Each edible shall be individually sealed in plain,
365 opaque wrapping marked only with the marijuana universal symbol.
366 Where practical, each edible shall be marked with the marijuana
367 universal symbol. In addition to the packaging and labeling
368 requirements in subparagraphs 10., and 11., and 12., edible
369 receptacles must be plain, opaque, and white without depictions
370 of the product or images other than the medical marijuana
371 treatment center’s department-approved logo and the marijuana
372 universal symbol. The receptacle must also include a list all of
373 the edible’s ingredients, storage instructions, an expiration
374 date, a legible and prominent warning to keep away from children
375 and pets, and a warning that the edible has not been produced or
376 inspected pursuant to federal food safety laws.
377 14. 13. When dispensing marijuana or a marijuana delivery
378 device, a medical marijuana treatment center:
379 a. May dispense any active, valid order for low-THC
380 cannabis, medical cannabis and cannabis delivery devices issued
381 pursuant to former s. 381.986, Florida Statutes 2016, which was
382 entered into the medical marijuana use registry before July 1,
384 b. May not dispense more than a 70-day supply of marijuana
385 to a qualified patient or caregiver.
386 c. Must have the medical marijuana treatment center’s
387 employee who dispenses the marijuana or a marijuana delivery
388 device enter into the medical marijuana use registry his or her
389 name or unique employee identifier.
390 d. Must verify that the qualified patient and the
391 caregiver, if applicable, each have an active registration in
392 the medical marijuana use registry and an active and valid
393 medical marijuana use registry identification card, the amount
394 and type of marijuana dispensed matches the physician
395 certification in the medical marijuana use registry for that
396 qualified patient, and the physician certification has not
397 already been filled.
398 e. May not dispense marijuana to a qualified patient who is
399 younger than 18 years of age. If the qualified patient is
400 younger than 18 years of age, marijuana may only be dispensed to
401 the qualified patient’s caregiver.
402 f. May not dispense or sell any other type of cannabis,
403 alcohol, or illicit drug-related product , including pipes,
404 bongs, or wrapping papers, other than a marijuana delivery
405 device required for the medical use of marijuana and which is
406 specified in a physician certification.
407 g. Must, upon dispensing the marijuana or marijuana
408 delivery device, record in the registry the date, time,
409 quantity, and form of marijuana dispensed; the type of marijuana
410 delivery device dispensed; and the name and medical marijuana
411 use registry identification number of the qualified patient or
412 caregiver to whom the marijuana delivery device was dispensed.
413 h. Must ensure that patient records are not visible to
414 anyone other than the qualified patient, his or her caregiver,
415 and authorized medical marijuana treatment center employees.
416 (14) EXCEPTIONS TO OTHER LAWS.—
417 (a) Notwithstanding s. 893.13, s. 893.135, s. 893.147, or
418 any other provision of law, but subject to the requirements of
419 this section, a qualified patient and the qualified patient’s
420 caregiver may purchase from a medical marijuana treatment center
421 for the patient’s medical use a marijuana delivery device and up
422 to the amount of marijuana authorized in the physician
423 certification, but may not possess more than a 70-day supply of
424 marijuana at any given time and all marijuana purchased must
425 remain in its original packaging.
426 (b) Notwithstanding paragraph (a), s. 893.13, s. 893.135,
427 s. 893.147, or any other provision of law, a qualified patient
428 and the qualified patient’s caregiver may purchase and possess a
429 marijuana delivery device intended for the medical use of
430 marijuana by smoking from a vendor other than a medical
431 marijuana treatment center if such delivery device, or a similar
432 delivery device, is specified in that patient’s certification
433 issued by a qualified physician.
434 (c) (b) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
435 or any other provision of law, but subject to the requirements
436 of this section, an approved medical marijuana treatment center
437 and its owners, managers, and employees may manufacture,
438 possess, sell, deliver, distribute, dispense, and lawfully
439 dispose of marijuana or a marijuana delivery device as provided
440 in this section, s. 381.988, and by department rule. For the
441 purposes of this subsection, the terms “manufacture,”
442 “possession,” “deliver,” “distribute,” and “dispense” have the
443 same meanings as provided in s. 893.02.
444 (d) (c) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
445 or any other provision of law, but subject to the requirements
446 of this section, a certified marijuana testing laboratory,
447 including an employee of a certified marijuana testing
448 laboratory acting within the scope of his or her employment, may
449 acquire, possess, test, transport, and lawfully dispose of
450 marijuana as provided in this section, in s. 381.988, and by
451 department rule.
452 (e) (d) A licensed medical marijuana treatment center and
453 its owners, managers, and employees are not subject to licensure
454 or regulation under chapter 465 or chapter 499 for
455 manufacturing, possessing, selling, delivering, distributing,
456 dispensing, or lawfully disposing of marijuana or a marijuana
457 delivery device, as provided in this section, in s. 381.988, and
458 by department rule.
459 (f) (e) This subsection does not exempt a person from
460 prosecution for a criminal offense related to impairment or
461 intoxication resulting from the medical use of marijuana or
462 relieve a person from any requirement under law to submit to a
463 breath, blood, urine, or other test to detect the presence of a
464 controlled substance.
465 (g) (f) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
466 or any other provision of law, but subject to the requirements
467 of this section and pursuant to policies and procedures
468 established pursuant to s. 1006.62(8), school personnel may
469 possess marijuana that is obtained for medical use pursuant to
470 this section by a student who is a qualified patient.
471 (h) (g) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
472 or any other provision of law, but subject to the requirements
473 of this section, a research institute established by a public
474 postsecondary educational institution, such as the H. Lee
475 Moffitt Cancer Center and Research Institute, Inc., established
476 under s. 1004.43, or a state university that has achieved the
477 preeminent state research university designation under s.
478 1001.7065 may possess, test, transport, and lawfully dispose of
479 marijuana for research purposes as provided by this section.
480 (15) APPLICABILITY.—
481 (a) This section does not limit the ability of an employer
482 to establish, continue, or enforce a drug-free workplace program
483 or policy.
484 (b) This section does not require an employer to
485 accommodate the medical use of marijuana in any workplace or any
486 employee working while under the influence of marijuana.
487 (c) This section does not create a cause of action against
488 an employer for wrongful discharge or discrimination.
489 (d) This section does not impair the ability of any party
490 to restrict or limit smoking on his or her private property.
491 (e) This section does not prohibit the medical use of
492 marijuana, or a caregiver assisting with the medical use of
493 marijuana, in a nursing home, licensed under part II of chapter
494 400; in a hospice facility, licensed under part IV of chapter
495 400; or in an assisted living facility, licensed under part I of
496 chapter 429, if the medical use of marijuana is not prohibited
497 in the facility’s policies.
498 (f) Marijuana, as defined in this section, is not
499 reimbursable under chapter 440.
500 Section 2. The proviso following Specific Appropriation 422
501 in section 3 of chapter 2018-9, Laws of Florida, and the proviso
502 following Specific Appropriation 424 in section 3 of chapter
503 2018-9, Laws of Florida, are repealed and the funds appropriated
504 by those specific appropriations which were affected by those
505 provisos are released from reserve.
506 Section 3. This act shall take effect upon becoming a law.
508 ================= T I T L E A M E N D M E N T ================
509 And the title is amended as follows:
510 Delete everything before the enacting clause
511 and insert:
512 A bill to be entitled
513 An act relating to the safe medical use of marijuana;
514 amending s. 381.986, F.S.; redefining the term
515 “marijuana delivery device” to eliminate the
516 requirement that such devices must be purchased from a
517 medical marijuana treatment center; redefining the
518 term “medical use” to include the possession, use, or
519 administration of marijuana in a form for smoking;
520 restricting smoking of marijuana in enclosed indoor
521 workplaces; conforming a provision to changes made by
522 the act; requiring a patient’s informed consent form
523 to include the risks specifically associated with
524 smoking marijuana; requiring a certifying physician to
525 make a determination in concurrence with a second
526 physician who meets specified requirements before
527 certifying a patient under 18 years of age who is not
528 diagnosed with a terminal condition to smoke marijuana
529 for medical use; requiring that marijuana in a form
530 for smoking meet certain packaging and labeling
531 requirements; deleting a provision prohibiting a
532 medical marijuana treatment center from dispensing or
533 selling specified products; allowing marijuana
534 delivery devices to be purchased from a vendor other
535 than a medical marijuana treatment center; providing
536 applicability; repealing proviso language in s. 3, ch.
537 2018-9, Laws of Florida, relating to salaries and
538 benefits positions and other personnel services of the
539 Department of Health; providing an effective date.